Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2012
Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity
Gillian C Barnett, Rebecca M Elliott, Jan Alsner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Annett Linge, Fabian Lohaus, Steffen Löck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Establishment of a Radiogenomics Consortium
Catharine West, Barry S Rosenstein, Jan Alsner, et al.
Breast Cancer Research : BCR
|
March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Miriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 3, 2022
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
Elnaz Naderi, Line M H Schack, Ceilidh Welsh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2014
Radiogenomics: radiobiology enters the era of big data and team science
Barry S Rosenstein, Catharine M West, Søren M Bentzen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 23, 2016
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Christian Nicolaj Andreassen, Barry S Rosenstein, Sarah L Kerns, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Clinical Proteomics
|
September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Ana M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2012
Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity
Gillian C Barnett, Rebecca M Elliott, Jan Alsner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Annett Linge, Fabian Lohaus, Steffen Löck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Establishment of a Radiogenomics Consortium
Catharine West, Barry S Rosenstein, Jan Alsner, et al.
Breast Cancer Research : BCR
|
March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Miriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 3, 2022
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
Elnaz Naderi, Line M H Schack, Ceilidh Welsh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2014
Radiogenomics: radiobiology enters the era of big data and team science
Barry S Rosenstein, Catharine M West, Søren M Bentzen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 23, 2016
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Christian Nicolaj Andreassen, Barry S Rosenstein, Sarah L Kerns, et al.
Page
of 15